Synthesis and in-vitro evaluation of anti-cancer drug

CHF 56.10
Auf Lager
SKU
1KHO8DLB4HT
Stock 1 Verfügbar
Geliefert zwischen Do., 13.11.2025 und Fr., 14.11.2025

Details

A series of 1-(substituted phenyl)-3-(4-oxo-2-phenylquinazolin-3(4H)-yl) urea were synthesized and evaluated for their cytotoxic activity against human cervical cancer cell line (HeLa) and NIH 3T3 mouse embryonic fibroblasts cell line by MTT assay method. We found that compound 2d inhibited proliferation of human cervical cancer cell line (HeLa) IC50 6.96(µM) concentration. Which was more potent than the standard 5-flourouracil (8.46 µM). Other compound was found to be a less potent. 2d could be further utilized for the design of newer and more effective anticancer agents against for cervical cancer. Since the compounds were synthesized in a few steps, they may be apt to an eco friendly approach at a large scale level.

Autorentext

Khushal DhamatMr.Khushal Dhamat had completed M.Pharmacy (Industrial Pharmacy) from Sumandeep Vidyapeeth, Vadodara. I had work on "Dissolution enhancement of Aceclofenac by complexation with B-Cyclodextrin" as research work. I had 6 publication in international and domestic journal.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Autor Khushal Dhamat , Chirag Bhalala , Chainesh Shah
    • Titel Synthesis and in-vitro evaluation of anti-cancer drug
    • ISBN 978-3-659-21484-4
    • Format Kartonierter Einband (Kt)
    • EAN 9783659214844
    • Jahr 2012
    • Größe H220mm x B150mm x T4mm
    • Untertitel Synthesis and in-vitro anticancer evaluation of 1-(sub. phenyl)-3-(4-oxo-2-phenylquinazolin-3(4h)-yl) urea derivatives
    • Gewicht 112g
    • Auflage Aufl.
    • Genre Medizin
    • Anzahl Seiten 64
    • Herausgeber LAP Lambert Academic Publishing
    • GTIN 09783659214844

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470